Australia’s only prime-time science show, Catalyst, discussed Tamiflu and the need the access for results from all clinical trials. The show interviews Dr Fiona Godlee, editor-in-chief of The BMJ and co-founder of AllTrials, and Professor Chris Del Mar, Coordinating Editor for the Acute Respiratory Group of the Cochrane Collaboration.
Narrator: The BMJ and Cochrane Collaboration are part of a global campaign called AllTrials.net. Its aim is to mitigate data suppression. It requires drug companies to register clinical trials and encourages full transparency of the results.
Dr Fiona Godlee: We now have a real sense that public and patient groups are beginning to understand that the current situation is not okay, that decisions being made on their behalf, decisions being made by them are not fully informed by all of the information. And I think that has been a real shift.
The Australian Government’s medical research funder and regulator, the National Health and Medical Research Council (NHMRC), joined AllTrials in November. Help us build the AllTrials campaign in Australia, sign the petition and get involved.